Form 4: Stoke Therapeutics CEO Edward M. Kaye Exercises Stock Options and Sells Shares
SEC Form 4 Filing
CEO Edward M. Kaye of Stoke Therapeutics exercised stock options and sold shares on March 15, 2025, according to a Form 4 filing with the SEC.
Summary
- On March 15, 2025, Edward M. Kaye, CEO of Stoke Therapeutics, exercised restricted stock units (RSUs) and sold the underlying common stock.
- He exercised RSUs representing 35,500 shares and 26,250 shares.
- Following these transactions, Kaye directly owns 132,385 shares and 158,635 shares of Stoke Therapeutics common stock.
- He also holds 71,000 and 78,750 derivative securities (RSUs).
Sentiment
Score: 5
Explanation: This is a routine disclosure of insider trading activity. The sentiment is neutral as it doesn't inherently indicate positive or negative news about the company's performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like the CEO, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects.
Stakeholder Impact
- Shareholders may be interested in the CEO's trading activity as an indicator of his confidence in the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Vesting start date for 1/4 of the total shares of one RSU award, annually, subject to continued service. |
| 03/15/2025 | Date of transactions: exercise of RSUs and sale of underlying shares; Vesting start date for 1/4 of the total shares of one RSU award, annually, subject to continued service. |
| 03/15/2027 | Expiration date for the restricted stock units representing 35,500 shares. |
| 03/15/2028 | Expiration date for the restricted stock units representing 26,250 shares. |
| 03/18/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.